Compare BZH & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZH | PSNL |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.0M | 729.1M |
| IPO Year | 1995 | 2019 |
| Metric | BZH | PSNL |
|---|---|---|
| Price | $22.51 | $6.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $32.00 | $12.20 |
| AVG Volume (30 Days) | 389.3K | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,087,739,000.00 | $69,648,000.00 |
| Revenue This Year | $4.36 | $15.47 |
| Revenue Next Year | $10.79 | $39.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.57 | $3.57 |
| 52 Week High | $28.33 | $11.50 |
| Indicator | BZH | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 39.71 |
| Support Level | $21.55 | $5.81 |
| Resistance Level | $24.42 | $9.56 |
| Average True Range (ATR) | 0.95 | 0.43 |
| MACD | 0.36 | 0.06 |
| Stochastic Oscillator | 71.82 | 34.15 |
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.